Halozyme Therapeutics Eulerpool Ziņas

Halozyme Therapeutics Eulerpool News

Halozyme Therapeutics Akciju Ziņas

Halozyme Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Halozyme Therapeutics ziņas mēs apkopojam šeit.

• 25. oktobris ·

  SeekingAlpha
  Artisan Global Equity Fund Q3 2024 Commentary
• 25. oktobris ·

  TipRanks
  Halozyme’s Patent Challenges and New Licensing Platform Lead to Hold Rating
• 25. oktobris ·

  Benzinga
  Unveiling 12 Analyst Insights On Halozyme Therapeutics
• 25. oktobris ·

  TipRanks
  Halozyme’s Strategic Balancing Act Amidst Patent Challenges: Hold Rating Maintained
• 25. oktobris ·

  TipRanks
  J.P. Morgan Sticks to Their Hold Rating for Halozyme (HALO)
• 25. oktobris ·

  TipRanks
  Positive Outlook for Halozyme: Strategic Position, Innovation, and Market Growth Drive Buy Rating
• 24. oktobris ·

  TipRanks
  Halozyme’s Strategic Resilience and Growth Potential Amid EU Patent Revocation
• 24. oktobris ·

  Yahoo
  HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
• 24. oktobris ·

  TipRanks
  Halozyme provides update following EPO decision to revoke Darzalex patent
• 23. oktobris ·

  Yahoo
  Halozyme to Report Third Quarter 2024 Financial and Operating Results